Nomogram for Predicting Risk of Cancer Therapy–Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Background Cancer therapy–related cardiac dysfunction (CTRCD) is an important treatment‐limiting toxicity for patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer that adversely affects cancer and cardiovascular outcomes. Easy‐to‐use tools that incorporate readily acc...

Descripción completa

Detalles Bibliográficos

Autores principales:	Anthony F. Yu, I‐Hsin Lin, Justine Jorgensen, Robert Copeland‐Halperin, Stephanie Feldman, Ishmam Ibtida, Amare Assefa, Michelle N. Johnson, Chau T. Dang, Jennifer E. Liu, Richard M. Steingart
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2023-10-01
Colección:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Materias:	breast cancer cardio‐oncology cardiotoxicity
Acceso en línea:	https://www.ahajournals.org/doi/10.1161/JAHA.123.029465
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!